Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

13.8K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
13.8K
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

1.1K
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
1.1K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.3K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.3K
Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

300
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
300
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

326
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
326

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Scalable Manufacturing of Amino Acid-Based Piezoelectric Biocrystal Films.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

BIOGEN: evidence-grounded multi-agent reasoning framework for transcriptomic interpretation in antimicrobial resistance.

Frontiers in bioinformatics·2026
Same author

Insights Into Dose-Dependent Bone Toxicity Following Partial-Body Exposure to Fractionated Ionizing Radiation In Vivo.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

Computational paradigms for antimicrobial resistance prediction: integrating multi-omics, structural modeling, and foundation artificial intelligence systems.

Briefings in bioinformatics·2026
Same author

The Catalytic Activity and Micro-Mechanisms of Reducible Metal Oxide Nanozymes in Relation to Their Antibacterial Efficacy.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Biomedical utility of zinc and copper mediated cerium oxide nanoparticles.

RSC advances·2026

Related Experiment Video

Updated: Sep 23, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

552

UnbiasedDTI: Mitigating Real-World Bias of Drug-Target Interaction Prediction by Using Deep Ensemble-Balanced

Aida Tayebi1, Niloofar Yousefi1, Mehdi Yazdani-Jahromi1

  • 1Department of Industrial Engineering and Management Systems, University of Central Florida, Orlando, FL 32816, USA.

Molecules (Basel, Switzerland)
|May 14, 2022
PubMed
Summary

Addressing class imbalance in drug-target interaction (DTI) prediction is crucial. This study introduces a deep learning framework that balances data, significantly improving DTI prediction accuracy over unbalanced models, validated experimentally.

Keywords:
ACE2 receptorSARS-CoV-2deep learningdrug-target interactionensemble learningmachine learningspike protein

More Related Videos

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

549
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.8K

Related Experiment Videos

Last Updated: Sep 23, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

552
Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

549
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.8K

Area of Science:

  • Computational chemistry and cheminformatics
  • Bioinformatics and computational biology
  • Machine learning in drug discovery

Background:

  • In vitro drug-target interaction (DTI) studies are costly and slow.
  • Computational DTI prediction offers efficiency but faces challenges.
  • Class imbalance, with far more negative than positive interactions, biases predictive models.

Purpose of the Study:

  • To develop a computational framework for DTI prediction that addresses class imbalance.
  • To evaluate the impact of data balancing on DTI prediction performance.
  • To validate computational predictions through experimental methods.

Main Methods:

  • An ensemble of deep learning models was employed for DTI prediction.
  • Data balancing techniques were specifically applied to mitigate class imbalance.
  • Model performance was assessed computationally and experimentally using the BindingDB dataset.

Main Results:

  • The proposed balanced deep learning model significantly outperformed unbalanced models.
  • Balancing the dataset reduced bias towards the majority negative class, enhancing predictive accuracy.
  • Experimental validation confirmed the superior performance of the balanced computational approach.

Conclusions:

  • Data balancing is critical for improving the accuracy of computational DTI prediction.
  • Deep learning models, when properly balanced, provide a powerful tool for drug discovery.
  • Experimental validation is essential for credible DTI prediction, especially with unbalanced datasets.